8,000 Shares in HCA Healthcare, Inc. $HCA Purchased by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 8,000 shares of the company’s stock, valued at approximately $3,786,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Sumitomo Life Insurance Co. raised its position in shares of HCA Healthcare by 1.0% in the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the last quarter. MJP Associates Inc. ADV raised its holdings in HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares during the last quarter. Anchyra Partners LLC boosted its stake in HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after buying an additional 21 shares during the last quarter. Finally, Cary Street Partners Financial LLC increased its stake in shares of HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after acquiring an additional 22 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.3%

Shares of HCA opened at $391.96 on Friday. The stock has a 50 day moving average price of $408.56 and a 200 day moving average price of $465.33. The company has a market capitalization of $86.95 billion, a price-to-earnings ratio of 13.48, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same period last year, the firm earned $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Leerink Partners cut their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Barclays cut their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Royal Bank Of Canada lowered their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Stephens decreased their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $503.00.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.